These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15542063)

  • 1. The iSH2 domain of PI 3-kinase is a rigid tether for p110 and not a conformational switch.
    Fu Z; Aronoff-Spencer E; Wu H; Gerfen GJ; Backer JM
    Arch Biochem Biophys; 2004 Dec; 432(2):244-51. PubMed ID: 15542063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit.
    Shekar SC; Wu H; Fu Z; Yip SC; Nagajyothi ; Cahill SM; Girvin ME; Backer JM
    J Biol Chem; 2005 Jul; 280(30):27850-5. PubMed ID: 15932879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
    Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of p85ni in class IA phosphoinositide 3-kinase exhibits interdomain disorder.
    Sen KI; Wu H; Backer JM; Gerfen GJ
    Biochemistry; 2010 Mar; 49(10):2159-66. PubMed ID: 20131869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.
    Wu H; Shekar SC; Flinn RJ; El-Sibai M; Jaiswal BS; Sen KI; Janakiraman V; Seshagiri S; Gerfen GJ; Girvin ME; Backer JM
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20258-63. PubMed ID: 19915146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the p85/p110alpha phosphatidylinositol 3'-kinase. Distinct roles for the n-terminal and c-terminal SH2 domains.
    Yu J; Wjasow C; Backer JM
    J Biol Chem; 1998 Nov; 273(46):30199-203. PubMed ID: 9804776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.
    Holt KH; Olson L; Moye-Rowley WS; Pessin JE
    Mol Cell Biol; 1994 Jan; 14(1):42-9. PubMed ID: 8264609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS).
    Burke JE; Williams RL
    Adv Biol Regul; 2013 Jan; 53(1):97-110. PubMed ID: 23194976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta.
    Hu P; Schlessinger J
    Mol Cell Biol; 1994 Apr; 14(4):2577-83. PubMed ID: 8139559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the iSH2 domain of human phosphatidylinositol 3-kinase p85β subunit reveals conformational plasticity in the interhelical turn region.
    Schauder C; Ma LC; Krug RM; Montelione GT; Guan R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec; 66(Pt 12):1567-71. PubMed ID: 21139197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism.
    Zhang X; Vadas O; Perisic O; Anderson KE; Clark J; Hawkins PT; Stephens LR; Williams RL
    Mol Cell; 2011 Mar; 41(5):567-78. PubMed ID: 21362552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation.
    Hale BG; Batty IH; Downes CP; Randall RE
    J Biol Chem; 2008 Jan; 283(3):1372-1380. PubMed ID: 18029356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.
    Dbouk HA; Pang H; Fiser A; Backer JM
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19897-902. PubMed ID: 21030680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity.
    Klippel A; Escobedo JA; Hirano M; Williams LT
    Mol Cell Biol; 1994 Apr; 14(4):2675-85. PubMed ID: 8139567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal domains of the class ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling.
    Hill KM; Huang Y; Yip SC; Yu J; Segall JE; Backer JM
    J Biol Chem; 2001 May; 276(19):16374-8. PubMed ID: 11278326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein.
    Hale BG; Kerry PS; Jackson D; Precious BL; Gray A; Killip MJ; Randall RE; Russell RJ
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1954-9. PubMed ID: 20133840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the nic96 subcomplex organization in the nuclear pore channel.
    Schrader N; Stelter P; Flemming D; Kunze R; Hurt E; Vetter IR
    Mol Cell; 2008 Jan; 29(1):46-55. PubMed ID: 18206968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nsp1p carboxy-terminal domain is organized into functionally distinct coiled-coil regions required for assembly of nucleoporin subcomplexes and nucleocytoplasmic transport.
    Bailer SM; Balduf C; Hurt E
    Mol Cell Biol; 2001 Dec; 21(23):7944-55. PubMed ID: 11689687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
    Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
    J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.